Advisor - HTA Statistics

Ashington, England, United Kingdom

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Candidates must possess a PhD with 3+ years of experience or a Master's degree with 6+ years of experience in statistics or a related field. Expertise in HTA, health outcomes research, and/or real-world evidence is required, along with significant experience in Health Technology Assessment in major markets and excellent knowledge of statistical theory and methodology, including experimental design and causal inference.

Responsibilities

The Advisor - HTA Statistics will provide statistical leadership for Health Technology Assessment (HTA) and reimbursement projects, translating strategic needs into statistical solutions and influencing cross-functional teams on research methods. Responsibilities include applying innovative statistical methodologies like economic modeling and meta-analysis, staying current with HTA statistical methods, overseeing external suppliers, communicating study results through submissions and presentations, and contributing to brand strategy and portfolio decisions.

Skills

Statistics

Health Technology Assessment (HTA)

Real-World Evidence (RWE)

Economic Modeling

Network Meta-Analysis

Indirect Comparisons

Clinical Trials

Statistical Methodology

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free